aluates Reports

$ 0.0

Automative

Global Conjugated Monoclonal Antibodies Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-37P9953

Global Conjugated Monoclonal Antibodies Market Insights Forecast to 2028

BUY CHAPTERS

Global Conjugated Monoclonal Antibodies Market Research Report 2025

Code: QYRE-Auto-37P9953

Report

July 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Roche Holding AG

Bristol–Myers Squibb

Merck and Co.

Immunomedics

Takeda Pharmaceuticals Industries Ltd

Daiichi Sankyo Company Limited

Spectrum Pharmaceuticals Inc

Actinium Pharmaceutical

Nordic Nanovector Inc.

Conjugated Monoclonal Antibodies Market

The global market for Conjugated Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Conjugated Monoclonal Antibodies are used to treat cancer because they deliver toxic substances directly to tumor cells by reducing damage to normal cells in other parts of the body.

North American market for Conjugated Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Conjugated Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Conjugated Monoclonal Antibodies in Blood Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Conjugated Monoclonal Antibodies include Pfizer, Roche Holding AG, Bristol-Myers Squibb, Merck and Co., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., Spectrum Pharmaceuticals Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Conjugated Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugated Monoclonal Antibodies.

The Conjugated Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Conjugated Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Conjugated Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Conjugated Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	Conjugated Monoclonal Antibodies Market
Segment by Type	Adcetris Kadcyla
Segment by Application	Blood Cancer Breast Cancer Ovarian Cancer Lung Cancer Brain Tumour Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Roche Holding AG, Bristol-Myers Squibb, Merck and Co., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., Spectrum Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Conjugated Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Conjugated Monoclonal Antibodies Market report?

Ans: The main players in the Conjugated Monoclonal Antibodies Market are Pfizer, Roche Holding AG, Bristol-Myers Squibb, Merck and Co., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Limited, Actinium Pharmaceutical, Nordic Nanovector Inc., Spectrum Pharmaceuticals Inc.

What are the Application segmentation covered in the Conjugated Monoclonal Antibodies Market report?

Ans: The Applications covered in the Conjugated Monoclonal Antibodies Market report are Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumour, Others

What are the Type segmentation covered in the Conjugated Monoclonal Antibodies Market report?

Ans: The Types covered in the Conjugated Monoclonal Antibodies Market report are Adcetris, Kadcyla

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Conjugated Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Adcetris

1.2.3 Kadcyla

1.3 Market by Application

1.3.1 Global Conjugated Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Blood Cancer

1.3.3 Breast Cancer

1.3.4 Ovarian Cancer

1.3.5 Lung Cancer

1.3.6 Brain Tumour

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Conjugated Monoclonal Antibodies Market Perspective (2020-2031)

2.2 Global Conjugated Monoclonal Antibodies Growth Trends by Region

2.2.1 Global Conjugated Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Conjugated Monoclonal Antibodies Historic Market Size by Region (2020-2025)

2.2.3 Conjugated Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)

2.3 Conjugated Monoclonal Antibodies Market Dynamics

2.3.1 Conjugated Monoclonal Antibodies Industry Trends

2.3.2 Conjugated Monoclonal Antibodies Market Drivers

2.3.3 Conjugated Monoclonal Antibodies Market Challenges

2.3.4 Conjugated Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Conjugated Monoclonal Antibodies Players by Revenue

3.1.1 Global Top Conjugated Monoclonal Antibodies Players by Revenue (2020-2025)

3.1.2 Global Conjugated Monoclonal Antibodies Revenue Market Share by Players (2020-2025)

3.2 Global Conjugated Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Conjugated Monoclonal Antibodies Revenue

3.4 Global Conjugated Monoclonal Antibodies Market Concentration Ratio

3.4.1 Global Conjugated Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Conjugated Monoclonal Antibodies Revenue in 2024

3.5 Global Key Players of Conjugated Monoclonal Antibodies Head office and Area Served

3.6 Global Key Players of Conjugated Monoclonal Antibodies, Product and Application

3.7 Global Key Players of Conjugated Monoclonal Antibodies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Conjugated Monoclonal Antibodies Breakdown Data by Type

4.1 Global Conjugated Monoclonal Antibodies Historic Market Size by Type (2020-2025)

4.2 Global Conjugated Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)

5 Conjugated Monoclonal Antibodies Breakdown Data by Application

5.1 Global Conjugated Monoclonal Antibodies Historic Market Size by Application (2020-2025)

5.2 Global Conjugated Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Conjugated Monoclonal Antibodies Market Size (2020-2031)

6.2 North America Conjugated Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Conjugated Monoclonal Antibodies Market Size by Country (2020-2025)

6.4 North America Conjugated Monoclonal Antibodies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Conjugated Monoclonal Antibodies Market Size (2020-2031)

7.2 Europe Conjugated Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Conjugated Monoclonal Antibodies Market Size by Country (2020-2025)

7.4 Europe Conjugated Monoclonal Antibodies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Conjugated Monoclonal Antibodies Market Size (2020-2031)

8.2 Asia-Pacific Conjugated Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Conjugated Monoclonal Antibodies Market Size by Region (2020-2025)

8.4 Asia-Pacific Conjugated Monoclonal Antibodies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Conjugated Monoclonal Antibodies Market Size (2020-2031)

9.2 Latin America Conjugated Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Conjugated Monoclonal Antibodies Market Size by Country (2020-2025)

9.4 Latin America Conjugated Monoclonal Antibodies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Conjugated Monoclonal Antibodies Market Size (2020-2031)

10.2 Middle East & Africa Conjugated Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Conjugated Monoclonal Antibodies Market Size by Country (2020-2025)

10.4 Middle East & Africa Conjugated Monoclonal Antibodies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Conjugated Monoclonal Antibodies Introduction

11.1.4 Pfizer Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Roche Holding AG

11.2.1 Roche Holding AG Company Details

11.2.2 Roche Holding AG Business Overview

11.2.3 Roche Holding AG Conjugated Monoclonal Antibodies Introduction

11.2.4 Roche Holding AG Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.2.5 Roche Holding AG Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Conjugated Monoclonal Antibodies Introduction

11.3.4 Bristol-Myers Squibb Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Merck and Co.

11.4.1 Merck and Co. Company Details

11.4.2 Merck and Co. Business Overview

11.4.3 Merck and Co. Conjugated Monoclonal Antibodies Introduction

11.4.4 Merck and Co. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.4.5 Merck and Co. Recent Development

11.5 Immunomedics Inc.

11.5.1 Immunomedics Inc. Company Details

11.5.2 Immunomedics Inc. Business Overview

11.5.3 Immunomedics Inc. Conjugated Monoclonal Antibodies Introduction

11.5.4 Immunomedics Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.5.5 Immunomedics Inc. Recent Development

11.6 Takeda Pharmaceuticals Industries Ltd.

11.6.1 Takeda Pharmaceuticals Industries Ltd. Company Details

11.6.2 Takeda Pharmaceuticals Industries Ltd. Business Overview

11.6.3 Takeda Pharmaceuticals Industries Ltd. Conjugated Monoclonal Antibodies Introduction

11.6.4 Takeda Pharmaceuticals Industries Ltd. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.6.5 Takeda Pharmaceuticals Industries Ltd. Recent Development

11.7 Daiichi Sankyo Company Limited

11.7.1 Daiichi Sankyo Company Limited Company Details

11.7.2 Daiichi Sankyo Company Limited Business Overview

11.7.3 Daiichi Sankyo Company Limited Conjugated Monoclonal Antibodies Introduction

11.7.4 Daiichi Sankyo Company Limited Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.7.5 Daiichi Sankyo Company Limited Recent Development

11.8 Actinium Pharmaceutical

11.8.1 Actinium Pharmaceutical Company Details

11.8.2 Actinium Pharmaceutical Business Overview

11.8.3 Actinium Pharmaceutical Conjugated Monoclonal Antibodies Introduction

11.8.4 Actinium Pharmaceutical Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.8.5 Actinium Pharmaceutical Recent Development

11.9 Nordic Nanovector Inc.

11.9.1 Nordic Nanovector Inc. Company Details

11.9.2 Nordic Nanovector Inc. Business Overview

11.9.3 Nordic Nanovector Inc. Conjugated Monoclonal Antibodies Introduction

11.9.4 Nordic Nanovector Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.9.5 Nordic Nanovector Inc. Recent Development

11.10 Spectrum Pharmaceuticals Inc.

11.10.1 Spectrum Pharmaceuticals Inc. Company Details

11.10.2 Spectrum Pharmaceuticals Inc. Business Overview

11.10.3 Spectrum Pharmaceuticals Inc. Conjugated Monoclonal Antibodies Introduction

11.10.4 Spectrum Pharmaceuticals Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025)

11.10.5 Spectrum Pharmaceuticals Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Roche Holding AG

Bristol–Myers Squibb

Merck and Co.

Immunomedics

Takeda Pharmaceuticals Industries Ltd

Daiichi Sankyo Company Limited

Spectrum Pharmaceuticals Inc

Actinium Pharmaceutical

Nordic Nanovector Inc.

List of Tables

Table 1. Global Conjugated Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Adcetris

Table 3. Key Players of Kadcyla

Table 4. Global Conjugated Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Conjugated Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Conjugated Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Conjugated Monoclonal Antibodies Market Share by Region (2020-2025)

Table 8. Global Conjugated Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Conjugated Monoclonal Antibodies Market Share by Region (2026-2031)

Table 10. Conjugated Monoclonal Antibodies Market Trends

Table 11. Conjugated Monoclonal Antibodies Market Drivers

Table 12. Conjugated Monoclonal Antibodies Market Challenges

Table 13. Conjugated Monoclonal Antibodies Market Restraints

Table 14. Global Conjugated Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Conjugated Monoclonal Antibodies Market Share by Players (2020-2025)

Table 16. Global Top Conjugated Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugated Monoclonal Antibodies as of 2024)

Table 17. Ranking of Global Top Conjugated Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Conjugated Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Conjugated Monoclonal Antibodies, Headquarters and Area Served

Table 20. Global Key Players of Conjugated Monoclonal Antibodies, Product and Application

Table 21. Global Key Players of Conjugated Monoclonal Antibodies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Conjugated Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Conjugated Monoclonal Antibodies Revenue Market Share by Type (2020-2025)

Table 25. Global Conjugated Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Conjugated Monoclonal Antibodies Revenue Market Share by Type (2026-2031)

Table 27. Global Conjugated Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Conjugated Monoclonal Antibodies Revenue Market Share by Application (2020-2025)

Table 29. Global Conjugated Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Conjugated Monoclonal Antibodies Revenue Market Share by Application (2026-2031)

Table 31. North America Conjugated Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Conjugated Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Conjugated Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Conjugated Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Conjugated Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Conjugated Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Conjugated Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Conjugated Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Conjugated Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Conjugated Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Conjugated Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Conjugated Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Conjugated Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Conjugated Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Conjugated Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Conjugated Monoclonal Antibodies Product

Table 49. Pfizer Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Roche Holding AG Company Details

Table 52. Roche Holding AG Business Overview

Table 53. Roche Holding AG Conjugated Monoclonal Antibodies Product

Table 54. Roche Holding AG Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 55. Roche Holding AG Recent Development

Table 56. Bristol-Myers Squibb Company Details

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Conjugated Monoclonal Antibodies Product

Table 59. Bristol-Myers Squibb Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. Merck and Co. Company Details

Table 62. Merck and Co. Business Overview

Table 63. Merck and Co. Conjugated Monoclonal Antibodies Product

Table 64. Merck and Co. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 65. Merck and Co. Recent Development

Table 66. Immunomedics Inc. Company Details

Table 67. Immunomedics Inc. Business Overview

Table 68. Immunomedics Inc. Conjugated Monoclonal Antibodies Product

Table 69. Immunomedics Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 70. Immunomedics Inc. Recent Development

Table 71. Takeda Pharmaceuticals Industries Ltd. Company Details

Table 72. Takeda Pharmaceuticals Industries Ltd. Business Overview

Table 73. Takeda Pharmaceuticals Industries Ltd. Conjugated Monoclonal Antibodies Product

Table 74. Takeda Pharmaceuticals Industries Ltd. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 75. Takeda Pharmaceuticals Industries Ltd. Recent Development

Table 76. Daiichi Sankyo Company Limited Company Details

Table 77. Daiichi Sankyo Company Limited Business Overview

Table 78. Daiichi Sankyo Company Limited Conjugated Monoclonal Antibodies Product

Table 79. Daiichi Sankyo Company Limited Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 80. Daiichi Sankyo Company Limited Recent Development

Table 81. Actinium Pharmaceutical Company Details

Table 82. Actinium Pharmaceutical Business Overview

Table 83. Actinium Pharmaceutical Conjugated Monoclonal Antibodies Product

Table 84. Actinium Pharmaceutical Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 85. Actinium Pharmaceutical Recent Development

Table 86. Nordic Nanovector Inc. Company Details

Table 87. Nordic Nanovector Inc. Business Overview

Table 88. Nordic Nanovector Inc. Conjugated Monoclonal Antibodies Product

Table 89. Nordic Nanovector Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 90. Nordic Nanovector Inc. Recent Development

Table 91. Spectrum Pharmaceuticals Inc. Company Details

Table 92. Spectrum Pharmaceuticals Inc. Business Overview

Table 93. Spectrum Pharmaceuticals Inc. Conjugated Monoclonal Antibodies Product

Table 94. Spectrum Pharmaceuticals Inc. Revenue in Conjugated Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 95. Spectrum Pharmaceuticals Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Conjugated Monoclonal Antibodies Picture

Figure 2. Global Conjugated Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Conjugated Monoclonal Antibodies Market Share by Type: 2024 VS 2031

Figure 4. Adcetris Features

Figure 5. Kadcyla Features

Figure 6. Global Conjugated Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Conjugated Monoclonal Antibodies Market Share by Application: 2024 VS 2031

Figure 8. Blood Cancer Case Studies

Figure 9. Breast Cancer Case Studies

Figure 10. Ovarian Cancer Case Studies

Figure 11. Lung Cancer Case Studies

Figure 12. Brain Tumour Case Studies

Figure 13. Others Case Studies

Figure 14. Conjugated Monoclonal Antibodies Report Years Considered

Figure 15. Global Conjugated Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Conjugated Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Conjugated Monoclonal Antibodies Market Share by Region: 2024 VS 2031

Figure 18. Global Conjugated Monoclonal Antibodies Market Share by Players in 2024

Figure 19. Global Top Conjugated Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugated Monoclonal Antibodies as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Conjugated Monoclonal Antibodies Revenue in 2024

Figure 21. North America Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Conjugated Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 23. United States Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Conjugated Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 27. Germany Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Conjugated Monoclonal Antibodies Market Share by Region (2020-2031)

Figure 35. China Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Conjugated Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 43. Mexico Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Conjugated Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 47. Turkey Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Conjugated Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 51. Roche Holding AG Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 53. Merck and Co. Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 54. Immunomedics Inc. Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 55. Takeda Pharmaceuticals Industries Ltd. Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 56. Daiichi Sankyo Company Limited Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 57. Actinium Pharmaceutical Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 58. Nordic Nanovector Inc. Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 59. Spectrum Pharmaceuticals Inc. Revenue Growth Rate in Conjugated Monoclonal Antibodies Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Antibody radionuclide Conjugates Market Research Report 2024

Global Ubiquitin Monoclonal Antibody Market Research Report 2024

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

Global Antibody PMO Conjugates Market Research Report 2024

Global Cancer Antibody Drug Conjugates Market Research Report 2024

Global Monoclonal Antibody for Gastric Cancer Market Research Report 2024

Global Myoglobin Monoclonal Antibody Market Research Report 2024

Global Fibronectin Monoclonal Antibody Market Research Report 2024

Global Anti CD20 Monoclonal Antibodies Market Research Report 2024

Global Transferrin Monoclonal Antibody Market Research Report 2024

Global Granulocytes Monoclonal Antibody Market Research Report 2024

Global Nuclear Antigen Monoclonal Antibody Market Research Report 2024

Global Erythrocytes Monoclonal Antibody Market Research Report 2024

Global Desmin Monoclonal Antibody Market Research Report 2024

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Global Antibody Drug Conjugate CDMO Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions